
AMPX does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for AMPX and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for AMPX and 80,000+ other tickers.
See exactly how AMPX's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AMPX and 80,000+ other tickers.
Amprius Technologies, Inc. is a company primarily focused on the development, production, and supply of advanced lithium-ion battery solutions. Their innovative product line notably includes cutting-edge silicon nanowire anode lithium-ion batteries. The firm's technological offerings cater to significant sectors such as aerospace, defense, and electric vehicle manufacturing. Founded in 2008, Amprius Technologies, Inc. operates from its headquarters located in Fremont, California.

Amprius Technologies NYSE: AMPX Q3 trend shift is shocking at face value, given the 68% correction in its share price over that period. During the quarter, shares were up as much as 3,877% from their 2024 lows, offering a compelling profit for early investors.

Agreement covers Amprius silicon-anode pouch cells from partial assembly through full cell production at CAMINUS's Indianapolis facility INDIANAPOLIS, Oct. 5, 2026 /PRNewswire/ -- CAMINUS (formerly EnPower), a U.S. manufacturer of lithium-ion battery cells and electrodes, today announced a contract manufacturing agreement with Amprius Technologies, Inc. (NYSE: AMPX), a developer and manufacturer of silicon-anode lithium-ion batteries. Under the agreement, CAMINUS will manufacture Amprius-designed pouch cells at its Indianapolis facility, adding domestic production capacity for Amprius customers in aviation, defense, and uncrewed systems.

Amprius Technologies NYSE: AMPX just received a new $75 million Department of War (DoW) grant that completely changes the narrative and strengthens the bull case. In short, the money shifts the company from a high-risk speculation with interesting technology to a primary, in-demand supplier for government needs, with an accelerated timeline to profitability.

[url="]Amprius Technologies[/url] (âAmpriusâ or the âCompanyâ) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies (“Amprius” or the “Company”) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $75 million from the U.S. Department of War (“DoW”) to retrofit an existing domestic production line from EV batteries to high-energy density cells for unmanned aerial systems. The grant was awarded through the DoW's Industrial Base Analysis and Sustainment (“IBAS”) program, which funds domestic manufacturing capabilities cri.